Condensed Consolidated Balance Sheets - USD ($) $ in Thousands |
Sep. 30, 2020 |
Dec. 31, 2019 |
| Current assets |
|
|
| Cash and cash equivalents |
$ 6,050
|
$ 5,812
|
| Restricted cash |
5
|
32
|
| Accounts receivable, net |
924
|
730
|
| Inventories |
963
|
927
|
| Prepaid expenses and other current assets |
497
|
330
|
| Total current assets |
8,439
|
7,831
|
| Property, plant and equipment, net |
460
|
633
|
| Intangible assets, net |
194
|
171
|
| Right-of-use assets |
367
|
203
|
| Deferred tax assets |
481
|
435
|
| Other assets |
61
|
59
|
| Total assets |
10,002
|
9,332
|
| Current liabilities |
|
|
| Accounts payable |
232
|
218
|
| Accrued liabilities |
370
|
302
|
| Lease liabilities, current |
230
|
154
|
| PPP loan payable |
186
|
|
| Accrued income taxes |
105
|
|
| Deferred revenue |
|
13
|
| Total current liabilities |
1,123
|
687
|
| Long term liabilities |
|
|
| Lease liabilities, long term |
165
|
66
|
| Deferred tax liabilities |
8
|
8
|
| Total long-term liabilities |
173
|
74
|
| Total liabilities |
1,296
|
761
|
| Commitments and contingencies (note 9) |
|
|
| Stockholders' equity |
|
|
| Common stock, $0.001 par value: 30,000 shares authorized, 6,601 and 6,563 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively |
7
|
7
|
| Additional paid-in-capital |
57,966
|
57,940
|
| Accumulated other comprehensive loss |
(44)
|
(93)
|
| Accumulated deficit |
(49,223)
|
(49,283)
|
| Total stockholders' equity |
8,706
|
8,571
|
| Total liabilities and stockholders' equity |
$ 10,002
|
$ 9,332
|